|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.41 USD | +1.08% |
|
+5.11% | +7.01% |
| 06-12 | Ionis Pharmaceuticals, Inc. Announces Executive Changes | CI |
| 06-12 | Ionis Pharmaceuticals Announces Dr Richard Geary, Chief Development Officer, To Retire | RE |
| Capitalization | 5.95B 5.16B 4.86B 4.42B 8.18B 516B 9.21B 57.61B 22.05B 236B 22.34B 21.87B 868B | P/E ratio 2025 * |
-12.1x | P/E ratio 2026 * | -11.9x |
|---|---|---|---|---|---|
| Enterprise value | 5.22B 4.53B 4.26B 3.88B 7.17B 452B 8.08B 50.5B 19.33B 207B 19.59B 19.17B 761B | EV / Sales 2025 * |
6.98x | EV / Sales 2026 * | 6.33x |
| Free-Float |
99.23% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Ionis Pharmaceuticals, Inc.
More recommendations
More press releases
More news
| 1 day | +1.08% | ||
| 1 week | +5.11% | ||
| Current month | +11.64% | ||
| 1 month | +8.53% | ||
| 3 months | +14.30% | ||
| 6 months | +5.00% | ||
| Current year | +7.01% |
| 1 week | 34.78 |  | 37.54 |
| 1 month | 32 | | 37.6 |
| Current year | 23.95 | | 37.6 |
| 1 year | 23.95 | | 52.34 |
| 3 years | 23.95 | | 54.44 |
| 5 years | 23.95 | | 64.37 |
| 10 years | 19.59 | | 86.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brett Monia
CEO | Chief Executive Officer | 63 | 31/12/2019 |
D. Walke
IRC | Investor Relations Contact | 59 | 30/06/2012 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 63 | 30/04/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
B. Parshall
BRD | Director/Board Member | 70 | 31/08/2000 |
Joseph Wender
BRD | Director/Board Member | 80 | 31/12/1993 |
Joseph Klein
BRD | Director/Board Member | 63 | 12/12/2005 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 6.89% | 1 M€ | -7.29% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | +5.11% | -8.33% | +6.10% | 5.95B | ||
| +0.39% | -1.51% | +16.56% | +14.23% | 48.43B | ||
| -40.00% | +142.71% | +35,996.87% | +3,297.09% | 18.8B | ||
| -2.25% | -8.36% | +58.85% | +86.98% | 29.32B | ||
| +0.08% | -1.38% | -27.76% | -21.44% | 26.77B | ||
| +1.25% | +0.87% | -1.65% | +20.79% | 26.16B | ||
| +0.10% | -1.36% | +11.76% | -17.45% | 12.32B | ||
| -1.14% | -4.17% | +150.59% | - | 11.83B | ||
| +2.02% | +0.56% | -53.65% | -27.08% | 11.64B | ||
| +3.63% | +3.57% | +45.45% | +110.80% | 10.68B | ||
| Average | -0.18% | +13.54% | +3,618.87% | +385.56% | 20.19B | |
| Weighted average by Cap. | -0.47% | +11.60% | +3,368.49% | +346.57% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 748M 649M 611M 555M 1.03B 64.76B 1.16B 7.23B 2.77B 29.67B 2.81B 2.75B 109B | 867M 752M 708M 643M 1.19B 75.07B 1.34B 8.39B 3.21B 34.39B 3.25B 3.18B 126B |
| Net income | -481M -418M -393M -357M -661M -41.7B -745M -4.66B -1.78B -19.1B -1.81B -1.77B -70.22B | -501M -434M -409M -372M -688M -43.37B -775M -4.85B -1.85B -19.87B -1.88B -1.84B -73.04B |
| Net Debt | -734M -637M -600M -545M -1.01B -63.61B -1.14B -7.11B -2.72B -29.14B -2.76B -2.7B -107B | -466M -404M -380M -346M -639M -40.32B -720M -4.5B -1.72B -18.47B -1.75B -1.71B -67.91B |
More financial data
* Estimated data
Employees
1,069
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/06/25 | 37.41 $ | +1.08% | 2,290,642 |
| 18/06/25 | 37.01 $ | +2.38% | 1,964,511 |
| 17/06/25 | 36.15 $ | +2.58% | 1,621,640 |
| 16/06/25 | 35.24 $ | -0.98% | 1,716,622 |
| 13/06/25 | 35.59 $ | -0.08% | 1,483,999 |
Delayed Quote Nasdaq, June 20, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
37.41USD
Average target price
57.66USD
Spread / Average Target
+54.12%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition